Neurodegeneration

The pursuit of treatments for neurodegeneration, including diseases like Alzheimer's, Parkinson's, and Huntington's, as well as addressing hallmarks like protein misfolding, polyglutamine repeats, neurofibrillary tangles.

LUX TAKE:

As humans live longer and longer lives, neurodegeneration is becoming a leading cause of death (Alzheimer's is the sixth leading cause of death in the U.S., for example). Today, no cures exist, but the urgency is rising, as the world's population of the aged is growing rapidly. Hundreds of potential compounds are in active clinical trials today, with popular approaches including the targeting of ...

Data last updated on July 18, 2019

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent neurodegeneration developments.

News Commentaries

An "arms race" is secretly brewing in Silicon Valley between consumer genomics players 23andMe and Helix Genomics (April 8, 2019)

New Lux Content

Using the health spectrum to highlight new business opportunities in a "superaging" demographic at the 2019 Lux Executive Briefing in Tokyo (June 12, 2019)

Intelligent Sensing: The Impact of AI on Sensor Capabilities (November 15, 2018)

New Patents

Genentech: Low affinity blood brain barrier receptor antibodies and uses thereof

Merck & Co: The chroman as the mglur2- voice allosteric mediatior, the dihydroisobenzofuran derivative only to this soak, and the composition and use thereof.

New Investment Rounds

Cognition Therapeutics has raised $3.3 million in grant funding (July 15, 2019)

vTv Therapeutics has raised $4 million in post-IPO funding (July 9, 2019)

Related companies	Alnylam Pharmaceuticals, Chrono Therapeutics, Oasis Diagnostics, Brainsway, Kinova Robotics, Empatica, Walk with Path, Intelesant, Manus Neurodynamica, BrainWaveBank, Vielight, Numerate, FeetMe, GTX Corp, Ixcela, iTraq, BenevolentAI, Dthera Sciences, TauRx Therapeutics, Intra-Cellular Therapies

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978